Aquatic Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-80
Closed -$8K 1410
2022
Q3
$8K Sell
80
-90
-53% -$12.8K ﹤0.01% 1063
2022
Q2
$38K Buy
+170
New +$56.9K 0.01% 704
2022
Q1
Sell
-70
Closed -$46K 1130
2021
Q4
$46K Buy
+70
New +$53.5K 0.09% 330

Other funds holding CDLX

Aquatic Capital Management's CDLX Position: Q4 2022 in Review

Aquatic Capital Management sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 80 shares — an estimated $8K sold.

Aquatic Capital Management first reported a position in CDLX in Q4 2021 and held it in 3 quarters. The position peaked at $46K in Q4 2021. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

  • Aquatic Capital Management reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 80 Cardlytics shares in Q4 2022, an estimated $8K.
  • Aquatic Capital Management first reported a position in Cardlytics in Q4 2021 and held it in 3 quarters.
  • Aquatic Capital Management's Cardlytics position peaked at $46K in Q4 2021.
  • 121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on Aquatic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.